Tag: Chemotherapy
ASCO: Pembrolizumab Noninferior to Chemo in Advanced Gastric Cancer
For patients with PD-L1 combined positive score of ≥10, pembrolizumab prolongs overall survival
Octogenarians With Acute Myeloid Leukemia Have Poor Survival
Overall survival 1.5 months; survival improved for those receiving chemotherapy
Fifteen Million Patients Will Need First-Course Chemo in 2040
Number of cancer physicians required to deliver optimal chemo set to increase to 100,000 by 2040
Test Predicts Benefit of Chemo in ER+, HER2− Breast Cancer
EndoPredict, a multigene test, helps predict whether adjuvant chemotherapy would be beneficial
New Lesions ID’d on Breast MRI During Treatment Likely Benign
New suspicious lesions detected on breast MRI during neoadjuvant therapy are more likely benign
Sucking Ice Chips Cuts Oral Side Effects of Oxaliplatin Chemo
Benefits include less trouble eating and fewer symptom-related negative effects on quality of life
Personalizing Breast Cancer Tx Could Cut Initial Costs of Care
Small decline seen in costs in first 12 months of care with personalized treatment based on recurrence scores
Neoadjuvant Chemotherapy Key to Survival in Pancreatic Cancer
Three factors independently linked to prolonged survival in BR/LA pancreatic ductal adenocarcinoma
AACR: Longer Survival With Gilteritinib in FLT3mut+ AML
Longer overall survival, better remission rates seen for patients receiving gilteritinib versus salvage chemo
Docetaxel Chemo Ups Survival in High-Risk Localized Prostate Cancer
Findings based on addition of docetaxel chemotherapy to androgen suppression, radiotherapy
